Skip to main content
The Journal of the American College of Clinical Wound Specialists logoLink to The Journal of the American College of Clinical Wound Specialists
. 2018 Jun 7;9(1-3):19–23. doi: 10.1016/j.jccw.2018.05.002

A Narrative Review of the Benefits and Risks of Total Contact Casts in the Management of Diabetic Foot Ulcers

Grace Messenger a,, Richard Masoetsa b, Imtiaz Hussain a
PMCID: PMC6304285  PMID: 30591897

Abstract

Total contact casts are recognized as the gold standard treatment for neuropathic plantar diabetic foot ulceration, endorsed by all national and international consensus papers. Despite this, research has shown that there is a dichotomy between the existing evidence which supports the use of total contact casts in the management of diabetic foot ulcers and its use in clinical practice. This article aims to highlight the benefits, risks, and barriers associated with total contact cast use in the management of diabetic foot ulcers in the clinical setting, with an emphasis on existing research carried out in this field to encourage change in clinical practice and utilization of this effective treatment modality.

Keywords: Diabetic foot ulcer, Total contact cast, Evidence-based medicine, Clinical practice, Risks and benefits

Abbreviations: DFU, Diabetic foot ulcer; DPN, Diabetic peripheral neuropathy; PAD, Peripheral arterial disease

Introduction

The lifetime risk of developing a diabetic foot ulcer (DFU) is believed to be as high as 12–25% in people with diabetes mellitus.1, 2 DFUs continue to be a leading cause of non-traumatic lower limb amputation3, 4 and precede 84% of lower limb amputations.5

Although the development of DFU is multifactorial, there are three main risk factors. Diabetic peripheral neuropathy (DPN) is considered the leading cause of DFU and is the causative factor in 35–45% of all DFUs.5, 6 These neuropathic DFUs usually occur on the plantar aspect of the foot.7 Peripheral arterial disease (PAD) in combination with DPN accounts for 24%–50% of DFUs and occur on the margins of the foot.6, 8, 9 Mechanical factors, such as foot deformity or limited joint mobility, cause increased plantar forces and tissue damage, resulting in DFU and delayed healing.10, 11, 12 Studies have shown that DFUs occur in areas of highest plantar pressure.13 However, a correlation between high frictional shear and DFU location compared to high plantar foot pressure has also been reported.14, 15 This suggests frictional shear represents another important factor, but further research is needed to understand this complex force fully. Consequently, one of the most important principles of healing a plantar DFU is reducing or redistributing pressure and shear from the affected site.4

A cornerstone in DFU management is pressure reduction through offloading. There are many products available to the clinician to reduce pressure from a DFU, including removable below knee devices and irremovable total contact casts. A total contact cast is a rigid or semi-rigid molded cast which extends from the patient's foot to just below the knee, maintaining contact with the entire plantar surface of the foot and lower leg and immobilizing surrounding joints and soft tissue while allowing the patient to remain ambulatory.16 A total contact cast uses minimal padding to protect the malleoli, tibia shaft and DFU.17 The use of padding provides total contact to the whole foot while isolating the DFU, and has been found to significantly reduce peak pressure (p = 0.008) and pressure-time integral (p-0.0012).18

This narrative review of the literature aims to explore the benefits and risks of total contact casts in the management of diabetic foot ulcer.

DFU management is costly with an estimated annual expenditure of between $9-$13 billion in the USA.19 The hospitalization of patients with DFU account for between 73.7% and 80% of the overall expenditure globally20, 21 and, leads to a longer length of stay.22 Private health insurance pay-outs almost double in patients with DFU when compared to patients without DFU ($28,031 vs $16,320 respectively).19 The estimated cost of a lower limb amputation is between $35,000-$45,000,23 although these figures do not include preceding DFU management or indirect costs associated with loss of productivity, family status or quality of life. Conversely, the use of total contact casts has shown substantial cost savings when compared to other treatments ($11,946 vs $22,494 per patient, respectively).24 In addition, a recent publication highlighted the cost-effectiveness of total contact cast and irremovable cast walkers when compared to removable walkers.25

In addition, all-cause DFU healing has been reported to be between 60% and 77%.26, 27 However, total contact casts have shown improved healing rates when compared to other off-loading devices in the treatment of plantar neuropathic DFU, with healing rates ranging from 89% to 92%,28, 29 and in some cases over a significantly shorter period.16, 30

Despite these benefits, Sinacore31 reported that 45% of clinics offered no off-loading in the management of DFU. More recently, studies have shown that total contact casts are not regularly used in the management of plantar DFU and footwear modification is the preferred method of off-loading despite its ineffectiveness in reducing plantar pressure and shearing forces.12, 32, 33 This is despite total contact casts being recognized as the gold standard treatment for plantar DFU by every consensus committee.32

Traditionally, it was believed that a total contact cast worked by equalizing plantar pressure, because the entire plantar surface of the foot was in contact with the internal surface of the cast, creating a larger surface area, redistributing pressure across the whole foot.17, 34 However, other authors have reported a reduction in plantar contact area as the load-bearing capacity of the rigid cast wall suspends the foot.35 Total contact casts have also shown a greater reduction in plantar load when compared to an ankle or below-ankle devices and removable below-knee walkers.16, 30, 35 The cast shank has been shown to remove 30%–36% of the pressure from the foot when compared to a cast shoe.33, 35, 36 Frictional shearing forces are also controlled as the foot is held firmly in position.35 When compared to shear-reducing walkers, total contact casts are associated with improved healing rates.37 This suggests there are several mechanisms which reduced pressure and shearing forces and improve DFU outcome and time-to-heal.

It is widely accepted that total contact casts ‘force compliance' as patients are unable to remove the cast.38 Armstrong and colleagues4 evaluated the difference between computerized accelerometers from waist-worn and those concealed in a removable cast walker in the same patients. The results showed that participants logged greater daily activity levels in the waist accelerometer compared with that found in the removable walker, which only recorded 28% of daily activity.4 This suggests patients wear removable below-knee walkers less than one-third of the time; whereas, a non-removable device forces compliance continuously. Patients treated with total contact casts are also significantly less active when compared to other off-loading devices, thus reducing the number of cycles of repetitive stress, and improving DFU healing.16 Shorter stride lengths and reduced walking speeds have also been recorded with the use of total contact casts, reducing vertical forces through the foot.39

Total contact casts can be contraindicated in certain circumstances. Some authors only recommend their use in non-infected neuropathic ulcers in the absence of PAD.37 However, Nabuurs-Franssen and colleagues30 conducted a study involving 98 patients with a combination of DPN, moderate PAD and infection (PEDIS grade ≤2). In this prospective non-randomized study, the researchers aimed to determine the outcome and complications of total contact casts in patients with DFU complicated by DPN, DPN and PAD, DPN and Infection or DPN, PAD and infection. They managed patients in either one or a combination of traditional total contact cast, removable bi-valve contact cast, and shoe-model cast. The authors found that patients with DPN or DPN and infection or DPN and PAD, healed 90%, 87% and 69% of the time, respectively. Importantly the authors reported rates of new ulceration and pre-ulcerative changes of 9% and 29%, respectively. Although, neither were related to PAD or infection and resolved before the main ulcer healed, suggesting patients with moderate PAD or infection are no more at risk of developing total contact cast complications than patients without PAD or infection. Patients with the triad of DPN, PAD, and infection had poorer outcomes, with healing only occurring in 36% of DFUs. The authors did not allude to the reason for this significant difference. However, it is well established that DFU with PAD and infection have the worst treatment outcomes.40 Though this trial was non-blinded and non-randomized, the use of total contact casts was found to improve DFU outcome in the presence of moderate PAD and infection and has now been endorsed by the International Working Group on the Diabetic Foot.41 However, patients must be monitored carefully, and the clinician should have a high degree of expertise in managing these types of wounds.

The decision to use a cast may be dependent on the level of exudate present around the wound. Highly exuding wounds may require daily dressing changes. In these circumstances, a bi-valve or removable cast may be considered42 or the creation of a window at the DFU site43

The most common side effects resulting from the use of total contact casts are skin abrasions or iatrogenic ulceration. However one study evaluating the development of iatrogenic ulceration found only 22 new ulcers in a sample of 398 casts, which equates to an iatrogenic ulceration rate of 5.52%, as important, the author reported no deterioration in the pre-existing DFU.44 Iatrogenic ulceration has also been found to heal before the primary ulcer.30 To reduce the risk of iatrogenic ulceration padding should be used to protect bony prominences, and patients should be advised to check for signs of bleeding or redness in exposed toes and to protect the contralateral leg with a long sock or pillowcase when in bed to reduce contact with the fiberglass cast.24 Patients should also be taught to check the integrity of the cast, and the treating clinician should review any problems.

The prolonged use of total contact casts has been associated with muscle atrophy and reduced bone density. To eliminate these problems. Carvaggi et al. (2000)43 first applied two layers of fiberglass for flexibility and resistance (Softcast 3 M; 3 M Health Care, St. Paul, MN). A second fiberglass bandage for high resistance to loading was used to reinforce the design (Scotchcast 3 M; 3 M Health Care). This was first placed between and extend beyond the two malleoli. A second layer was then applied to the plantar aspect of the cast, which gave the cast a rigid construct. They found that using a combination of rigid and semi-rigid casting materials minimized these complications.43 In addition, the introduction of a gait rehabilitation programme may reduce the adverse effects of muscle atrophy and loss of bone density, although this has yet to be examined.

Leg length discrepancy can also occur, resulting in either new or worsening postural instability.45 This should be considered during patient selection. Low-profile casts can be used with a lightweight material to minimize instability,35 or patients can purchase shoe balancers for the contralateral limb.

The application of a total contact cast requires skill, is labor intensive and takes time.24 However, with advancements in technology clinicians now have access to instant total contact casts (using fiberglass roll or zip ties to make a removable off-the-shelf below knee walker into a non-removable walker) and total contact cast systems, such as TCC-EZ® (Derma Sciences).

These new systems can reduce application time, with one study reporting a mean TCC-EZ® application time of 21 min,46 and have shown equal effectiveness in the management of DFU.47, 48 Finally, training in the application of traditional fiberglass casts remains readily available.

Conclusion

DFUs continue to be a leading cause of non-traumatic lower limb amputation. Although no single off-loading device is suitable for every patient and decisions should be made on a case-by-case basis, the benefits of total contact casts far outweigh the risks involved.

This paper has demonstrated that the risk of total contact casts. In most cases, this is minor iatrogenic tissue damage, which can be resolved by proper padding applications, and gait instability as a result of acquired leg length discrepancy, which can be managed by the provision of low-profile casts and shoe balancers for the opposite foot.

On the contrary, the benefit, for most, is improved compliance with offloading, speedy ulcer healing, and the patient can maintain a degree of mobility and continue to be productive in the family/community.

Total contact casts area gold standard in the treatment of plantar diabetic foot ulcers. However, adequate training in the application of total contact cast is required to reduce complications. Advancements in technology have been made giving clinicians new options such as an instant total contact cast and a TCC-EZ®, which are easier and quicker to apply.

The perceived risks and barriers in using total contact cast must be offset by the high cost of DFU treatment and high rate of lower leg amputation and the associated impact on patient morbidity and mortality. Clinicians can no longer ignore the vast body of evidence which supports the use of total contact casts in clinical practice. It is time healthcare professionals utilize this treatment modality as the standard off-loading therapy in appropriate DFU management in line with evidence-based guidance.

Authors contributions

GM was responsible for writing the manuscript. RM and IH were responsible for reviewing the manuscript.

Declaration of interest

None.

Acknowledgments

The authors would like to acknowledge the support they have received from Dr. Ebaa Al Ozairi, Chief Medical Officer and The Kuwait Foundation for the Advancement of Science (KFAS). They would also like to thank the staff members in the Podiatry department and Clinical Services, Dasman Diabetes Institute.

References

  • 1.Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–228. doi: 10.1001/jama.293.2.217. [DOI] [PubMed] [Google Scholar]
  • 2.Reiber G.E., Vileikyte L., Boyko E.J. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157–162. doi: 10.2337/diacare.22.1.157. [DOI] [PubMed] [Google Scholar]
  • 3.Boulton A.J. The diabetic foot: grand overview, epidemiology, and pathogenesis. Diabetes Metab Res Rev. 2008;24(Suppl 1):S3–S6. doi: 10.1002/dmrr.833. [DOI] [PubMed] [Google Scholar]
  • 4.Armstrong D.G., Lavery L.A., Kimbriel H.R., Nixon B.P., Boulton A.J. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care. 2003;26(9):2595–2597. doi: 10.2337/diacare.26.9.2595. [DOI] [PubMed] [Google Scholar]
  • 5.Pecoraro R.E., Reiber G.E., Burgess E.M. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13(5):513–521. doi: 10.2337/diacare.13.5.513. [DOI] [PubMed] [Google Scholar]
  • 6.Armstrong D.G., Cohen K., Courric S., Bharara M., Marston W. Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not. J Diabetes Sci Technol. 2011;5(6):1591–1595. doi: 10.1177/193229681100500636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Edmonds M.E., Foster A.V. Diabetic foot ulcers. BMJ. 2006;332(7538):407–410. doi: 10.1136/bmj.332.7538.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Moulik P.K., Mtonga R., Gill G.V. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491–494. doi: 10.2337/diacare.26.2.491. [DOI] [PubMed] [Google Scholar]
  • 9.Mills J.L., Sr., Conte M.S., Armstrong D.G. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI) J Vasc Surg. 2014;59(1) doi: 10.1016/j.jvs.2013.08.003. 220–234.e1-2. [DOI] [PubMed] [Google Scholar]
  • 10.Frykberg R.G., Lavery L.A., Pham H., Harvey C., Harkless L., Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714–1719. doi: 10.2337/diacare.21.10.1714. [DOI] [PubMed] [Google Scholar]
  • 11.Cavanagh P.R., Bus S.A. Off-loading the diabetic foot for ulcer prevention and healing. J Am Podiatr Med Assoc. 2010;100(5):360–368. doi: 10.7547/1000360. [DOI] [PubMed] [Google Scholar]
  • 12.Wu S.C., Jensen J.L., Weber A.K., Robinson D.E., Armstrong D.G. Use of pressure offloading devices in diabetic foot ulcers: do we practice what we preach? Diabetes Care. 2008;31(11):2118–2119. doi: 10.2337/dc08-0771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Armstrong D.G., Lavery L.A. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998;57(6):1325–1332. 1337-8. [PubMed] [Google Scholar]
  • 14.Yavuz M. Plantar shear stress distributions in diabetic patients with and without neuropathy. Clin Biomech. 2014;29(2):223. doi: 10.1016/j.clinbiomech.2013.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yavuz M., Master H., Garrett A., Lavery L.A., Adams L.S. Peak plantar shear and pressure and foot ulcer locations: a call to revisit ulceration pathomechanics. Diabetes Care. 2015;38(11):e184–e185. doi: 10.2337/dc15-1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Armstrong D.G., Nguyen H.C., Lavery L.A., van Schie C.H., Boulton A.J., Harkless L.B. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24(6):1019–1022. doi: 10.2337/diacare.24.6.1019. [DOI] [PubMed] [Google Scholar]
  • 17.Novick A., Birke J.A., Graham S.L., Koziatek E. Effect of a walking splint and total contact casts on plantar forces. JPO J Prosthetics Orthot. 1991;3(4):168–178. [Google Scholar]
  • 18.Petre M., Tokar P., Kostar D., Cavanagh P.R. Revisiting the total contact cast: maximizing off-loading by wound isolation. Diabetes Care. 2005;28(4):929–930. doi: 10.2337/diacare.28.4.929. [DOI] [PubMed] [Google Scholar]
  • 19.Rice J.B., Desai U., Cummings A.K., Birnbaum H.G., Skornicki M., Parsons N.B. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014;37(3):651–658. doi: 10.2337/dc13-2176. [DOI] [PubMed] [Google Scholar]
  • 20.Harrington C., Zagari M.J., Corea J., Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care. 2000;23(9):1333–1338. doi: 10.2337/diacare.23.9.1333. [DOI] [PubMed] [Google Scholar]
  • 21.Holzer S.E., Camerota A., Martens L., Cuerdon T., Crystal-Peters J., Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20(1):169–181. doi: 10.1016/s0149-2918(98)80044-1. [DOI] [PubMed] [Google Scholar]
  • 22.Kerr M., Rayman G., Jeffcoate W.J. Cost of diabetic foot disease to the national health service in England. Diabet Med. 2014;31(12):1498–1504. doi: 10.1111/dme.12545. [DOI] [PubMed] [Google Scholar]
  • 23.Petrakis I., Kyriopoulos I.J., Ginis A., Athanasakis K. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications. Expert Rev Pharmacoecon Outcomes Res. 2017;17(2):165–180. doi: 10.1080/14737167.2017.1305891. [DOI] [PubMed] [Google Scholar]
  • 24.Rogers L.C. Overcoming barriers to adopting the total contact cast in your practice. Podiatr Today. 2015;28(8) p. n.p. [Google Scholar]
  • 25.Health Quality Ontario . Ontario Health Technology Assess Ser; 2017. Fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: a health technology assessment; p. 124. [PMC free article] [PubMed] [Google Scholar]
  • 26.Jeffcoate W.J., Chipchase S.Y., Ince P., Game F.L. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29(8):1784–1787. doi: 10.2337/dc06-0306. [DOI] [PubMed] [Google Scholar]
  • 27.Mehmood K., Akhtar S.T., Talib A., Abbasi B., Siraj ul S., Naqvi I.H. Clinical profile and management outcome of diabetic foot ulcers in a tertiary care hospital. J Coll Phys Surg Pak. 2008;18(7):408–412. [PubMed] [Google Scholar]
  • 28.Ali R., Qureshi A., Yaqoob M.Y., Shakil M. Total contact cast for neuropathic diabetic foot ulcers. J Coll Phys Surg Pak. 2008;18(11):695–698. [PubMed] [Google Scholar]
  • 29.Ganguly S., Chakraborty K., Mandal A comparative study between total contact casting and conventional dressings in the non-surgical management of diabetic plantar foot ulcers. J Indian Med Assoc. 2008;106(4):237–239. 244. [PubMed] [Google Scholar]
  • 30.Nabuurs-Franssen M.H., Sleegers R., Huijberts M.S. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care. 2005;28(2):243–247. doi: 10.2337/diacare.28.2.243. [DOI] [PubMed] [Google Scholar]
  • 31.Sinacore D.R. Total contact casting for diabetic neuropathic ulcers. Phys Ther. 1996;76(3):296–301. doi: 10.1093/ptj/76.3.296. [DOI] [PubMed] [Google Scholar]
  • 32.Fife C.E., Carter M.J., Walker D. Why is it so hard to do the right thing in wound care? Wound Repair Regen. 2010;18(2):154–158. doi: 10.1111/j.1524-475X.2010.00571.x. [DOI] [PubMed] [Google Scholar]
  • 33.Leibner E.D. Unloading mechanism in the total contact cast. Foot Ankle Int. 2006;27(4):281–285. doi: 10.1177/107110070602700409. [DOI] [PubMed] [Google Scholar]
  • 34.Gutekunst D.J., Hastings M.K., Bohnert K.L., Strube M.J., Sinacore D.R. Removable cast walker boots yield greater forefoot off-loading than total contact casts. Clin Biomech (Bristol, Avon) 2011;26(6):649–654. doi: 10.1016/j.clinbiomech.2011.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Begg L., McLaughlin P., Vicaretti M., Fletcher J., Burns J. Total contact cast wall load in patients with a plantar forefoot ulcer and diabetes. J Foot Ankle Res. 2016;9:2. doi: 10.1186/s13047-015-0119-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Shaw J.E., Hsi W.-L., Ulbrecht J.S., Norkitis A., Becker M.B., Cavanagh P.R. The mechanism of plantar unloading in total contact casts: implications for design and clinical use. Foot Ankle Int. 1997;18(12):809–817. doi: 10.1177/107110079701801210. [DOI] [PubMed] [Google Scholar]
  • 37.Lavery L.A., Higgins K.R., La Fontaine J., Zamorano R.G., Constantinides G.P., Kim P.J. Randomised clinical trial to compare total contact casts, healing sandals and a shear-reducing removable boot to heal diabetic foot ulcers. Int Wound J. 2015;12(6):710–715. doi: 10.1111/iwj.12213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Armstrong D.G., Lavery L.A. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34(3):317–321. [PubMed] [Google Scholar]
  • 39.Hartsell H.D., Brand R.A., Saltzman C.L. Total contact casting: its effect on contralateral plantar foot pressure. Foot Ankle Int. 2002;23(4):330–334. doi: 10.1177/107110070202300407. [DOI] [PubMed] [Google Scholar]
  • 40.Armstrong D.G., Lavery L.A., Harkless L.B. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855–859. doi: 10.2337/diacare.21.5.855. [DOI] [PubMed] [Google Scholar]
  • 41.Bus S., Netten J., Lavery L. IWGDF Guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metabol Res Rev. 2016;32(S1):16–24. doi: 10.1002/dmrr.2696. [DOI] [PubMed] [Google Scholar]
  • 42.Armstrong D., Isaac A., Bevilacqua N., Wu S. Offloading foot wounds in people with diabetes. Wounds. 2014;26(1):13–20. [Google Scholar]
  • 43.Caravaggi C., Faglia E., De Giglio R. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care. 2000;23(12):1746–1751. doi: 10.2337/diacare.23.12.1746. [DOI] [PubMed] [Google Scholar]
  • 44.Guyton G.P. An analysis of iatrogenic complications from the total contact cast. Foot Ankle Int. 2005;26(11):903–907. doi: 10.1177/107110070502601101. [DOI] [PubMed] [Google Scholar]
  • 45.Van De Weg F.B., Van Der Windt D.A., Vahl A.C. Wound healing: total contact cast vs. custom-made temporary footwear for patients with diabetic foot ulceration. Prosthet Orthot Int. 2008;32(1):3–11. doi: 10.1080/03093640701318672. [DOI] [PubMed] [Google Scholar]
  • 46.Jensen J., Jaakola E., Gillin B., Riley E. Diabetic Foot Global Conference. 2008. TCC-EZ–total Contact Casting System Overcoming the Barriers to Utilizing a Proven Gold Standard Treatment. [Google Scholar]
  • 47.Morona J.K., Buckley E.S., Jones S., Reddin E.A., Merlin T.L. Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis. Diabetes Metabol Res Rev. 2013;29(3):183–193. doi: 10.1002/dmrr.2386. [DOI] [PubMed] [Google Scholar]
  • 48.Faglia E., Caravaggi C., Clerici G. Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer. Diabetes Care. 2010;33(7):1419–1423. doi: 10.2337/dc09-1708. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of the American College of Clinical Wound Specialists are provided here courtesy of Elsevier

RESOURCES